IMV (Canada) Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 63

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 11

  • Investments
  • 2

IMV (Canada) General Information

Description

IMV Inc is a clinical-stage biopharmaceutical company developing a novel class of cancer vaccines based on DPX, its immune-educating technology platform. DPX is designed to inform a specific, coordinated and persistent anti-tumor immune response, that could change the lives of patients with cancer. Its therapeutic candidate, maveropepimut-S (MVP-S), is a DPX-based cancer vaccine that delivers antigenic peptides from survivin, a well-recognized cancer antigen commonly overexpressed in cancers. The company has one reportable and geographic segment.

Contact Information

Website
www.imv-inc.com
Formerly Known As
Immunovaccine, hino Resources Inc.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 130 Eileen Stubbs Avenue
  • Suite 19
  • Dartmouth, Nova Scotia B3B 2C4
  • Canada
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Former Stock Listing
IMVIF
Corporate Office
  • 130 Eileen Stubbs Avenue
  • Suite 19
  • Dartmouth, Nova Scotia B3B 2C4
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IMV (Canada) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IMV (Canada)‘s full profile, request access.

Request a free trial

IMV (Canada) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
IMV Inc is a clinical-stage biopharmaceutical company developing a novel class of cancer vaccines based on DPX, its immu
Biotechnology
Dartmouth, Canada
63 As of 2022

Princeton, NJ
 

San Carlos, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IMV (Canada) Competitors (17)

One of IMV (Canada)’s 17 competitors is PDS Biotechnology, a Formerly VC-backed company based in Princeton, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PDS Biotechnology Formerly VC-backed Princeton, NJ
Iovance Biotherapeutics Corporation San Carlos, CA
Fate Therapeutics Formerly VC-backed San Diego, CA
Sorrento Therapeutics Formerly VC-backed San Diego, CA
Mersana Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 5 of 17 competitors. Get the full list »

IMV (Canada) Patents

IMV (Canada) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024092352-A1 Compositions that recruit and activate antigen presenting cells Inactive 04-Nov-2022
AU-2022354218-A1 Survivin and mage-a9 dual-targeted immunotherapy Pending 29-Sep-2021
US-20240390468-A1 Survivin and mage-a9 dual-targeted immunotherapy Inactive 29-Sep-2021
WO-2023052842-A1 Survivin and mage-a9 dual-targeted immunotherapy Inactive 29-Sep-2021
WO-2023052842-A9 Survivin and mage-a9 dual-targeted immunotherapy Inactive 29-Sep-2021 A61K40/4268
To view IMV (Canada)’s complete patent history, request access »

IMV (Canada) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IMV (Canada) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore IMV (Canada)‘s full profile, request access.

Request a free trial

IMV (Canada) Acquisitions (2)

IMV (Canada)’s most recent deal was a Merger/Acquisition with Rhino Resources. The deal was made on 30-Sep-2009.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Rhino Resources 30-Sep-2009 Merger/Acquisition Holding Companies
Immunotope 01-Jun-2008 Merger/Acquisition Drug Discovery
To view IMV (Canada)’s complete acquisitions history, request access »

IMV (Canada) Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Immunotope Doylestown, PA 2002

IMV (Canada) FAQs

  • When was IMV (Canada) founded?

    IMV (Canada) was founded in 2000.

  • Where is IMV (Canada) headquartered?

    IMV (Canada) is headquartered in Dartmouth, Canada.

  • What is the size of IMV (Canada)?

    IMV (Canada) has 63 total employees.

  • What industry is IMV (Canada) in?

    IMV (Canada)’s primary industry is Biotechnology.

  • Is IMV (Canada) a private or public company?

    IMV (Canada) is a Private company.

  • What is the current valuation of IMV (Canada)?

    The current valuation of IMV (Canada) is .

  • What is IMV (Canada)’s current revenue?

    The current revenue for IMV (Canada) is .

  • How much funding has IMV (Canada) raised over time?

    IMV (Canada) has raised $45.6M.

  • Who are IMV (Canada)’s investors?

    Altium Capital Management, CTI Life Sciences Fund, Cato BioVentures, First Angel Network, and Fonds de solidarite FTQ are 5 of 8 investors who have invested in IMV (Canada).

  • Who are IMV (Canada)’s competitors?

    PDS Biotechnology, Iovance Biotherapeutics, Fate Therapeutics, Sorrento Therapeutics, and Mersana Therapeutics are some of the 17 competitors of IMV (Canada).

  • When was IMV (Canada) acquired?

    IMV (Canada) was acquired on 11-Feb-2024.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process